HIV-1 molecular epidemiology evidence and transmission patterns in the Middle East and North Africa

Sexually Transmitted Infections

Volumn 87, Issue 2, 2011, Pages 101-106

  Mumtaz, Ghina ^a   Hilmi, Nahla ^b   Akala, Francisca Ayodeji ^b   Semini, Iris ^c   Riedner, Gabriele ^d   Wilson, David ^b   Abu Raddad, Laith J ^a,e,f  

^a Department of Obstetrics Gynecology   (Qatar)

^b WORLD BANK   (United States)

^c Middle East and North Africa   (Egypt)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

^f Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL; EPIDEMIC; GENETIC VARIABILITY; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INTRAVENOUS DRUG ABUSE; MIDDLE EAST; MOLECULAR EPIDEMIOLOGY; NONHUMAN; NORTH AFRICA; PRIORITY JOURNAL; PROSTITUTION; SYSTEMATIC REVIEW; VIRUS TRANSMISSION;

AFRICA, NORTHERN; FEMALE; GENETIC VARIATION; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE EAST; MOLECULAR EPIDEMIOLOGY;

EID: 79952105256     PISSN: 13684973     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/sti.2010.043711     Document Type: Article

References (47)

1. Woodman Z, Williamson C. HIV molecular epidemiology: transmission and adaptation to human populations. Curr Opin HIV AIDS 2009;4:247-52.
2. Buonaguro L, Tornesello ML, Buonaguro FM. Human immunodeficiency virus type 1 subtype distribution in the worldwide epidemic: pathogenetic and therapeutic implications. J Virol 2007;81:10209-19. (Pubitemid 47463296)
3. Papathanasopoulos MA, Hunt GM, Tiemessen CT. Evolution and diversity of HIV-1 in Africa - a review. Virus Genes 2003;26:151-63. (Pubitemid 36656336)
4. Tatt ID, Barlow KL, Nicoll A, et al. The public health significance of HIV-1 subtypes. AIDS 2001;15(Suppl 5):S59-71.
5. Abu-Raddad LJ, Hilmi N, Mumtaz G, et al. Epidemiology of HIV infection in the Middle East and North Africa. AIDS 2010;24(Suppl 2):S5-23.
6. Abu-Raddad L, Akala FA, Semini I, et al. Characterizing the HIV/AIDS epidemic in the Middle East and North Africa: time for strategic action. Middle East and North Africa HIV/AIDS Epidemiology Synthesis Project. Washington DC, USA: World Bank/UNAIDS/WHO Publication, 2010.
7. Los Alamos HIV database, National Institute of Allergy and Infectious Diseases (NIAID). http://www.hiv.lanl.gov/content/index (accessed Feb 2010).
8. Sanders-Buell E, Saad MD, Abed AM, et al. A nascent HIV type 1 epidemic among injecting drug users in Kabul, Afghanistan is dominated by complex AD recombinant strain, CRF35-AD. AIDS Res Hum Retroviruses 2007;23:834-9. (Pubitemid 47047924)
9. Bouzeghoub S, Jauvin V, Recordon-Pinson P, et al. High diversity of HIV type 1 in Algeria. AIDS Res Hum Retroviruses 2006;22:367-72.
10. Maslin J, Rogier C, Berger F, et al. Epidemiology and genetic characterization of HIV-1 isolates in the general population of Djibouti (Horn of Africa). J Acquir Immune Defic Syndr 2005;39:129-32. (Pubitemid 40741108)
11. Lasky M, Perret JL, Peeters M, et al. Presence of multiple non-B subtypes and divergent subtype B strains of HIV-1 in individuals infected after overseas deployment. AIDS 1997;11:43-51. (Pubitemid 27023211)
12. Sarrami-Forooshani R, Das SR, Sabahi F, et al. Molecular analysis and phylogenetic characterization of HIV in Iran. J Med Virol 2006;78:853-63. (Pubitemid 43862453)
13. Naderi HR, Tagliamonte M, Tornesello ML, et al. Molecular and phylogenetic analysis of HIV-1 variants circulating among injecting drug users in Mashhad, Iran. Infect Agent Cancer 2006;1:4.
14. Soheilli ZS, Ataiee Z, Tootian S, et al. Presence of HIV-1 CRF35-AD in Iran. AIDS Res Hum Retroviruses 2009;25:123-4.
15. Mousavi SM, Hamkar R, Gouya MM, et al. Surveillance of HIV drug resistance transmission in Iran: experience gained from a pilot study. Arch Virol 2010;155:329-34.
16. Hamkar R, Mohraz M, Lorestani S, et al. Assessing subtype and drug-resistance associated mutations among antiretroviral-treated HIV-infected patients. AIDS 2010;24(Suppl 2):S85-91.
17. Gehring S, Maayan S, Ruppach H, et al. Molecular epidemiology of HIV in Israel. J Acquir Immune Defic Syndr Hum Retrovirol 1997;15:296-303. (Pubitemid 27432727)
18. Pieniazek D, Baggs J, Hu DJ, et al. Introduction of HIV-2 and multiple HIV-1 subtypes to Lebanon. Emerg Infect Dis 1998;4:649-56. (Pubitemid 28553692)
19. de Oliveira T, Pybus OG, Rambaut A, et al. Molecular epidemiology: HIV-1 and HCV sequences from Libyan outbreak. Nature 2006;444:836-7. (Pubitemid 46024988)
20. Elharti E, Elaouad R, Amzazi S, et al. HIV-1 diversity in Morocco. AIDS 1997;11:1781-3.
21. Abid M, Luo CC, Sekkat S, et al. Characterization of the V3 region of HIV type 1 isolates from Morocco. AIDS Res Hum Retroviruses 1998;14:1387-9. (Pubitemid 28465273)
22. Bakhouch K, Oulad-Lahcen A, Bensghir R, et al. The prevalence of resistance-associated mutations to protease and reverse transcriptase inhibitors in treatment-naive (HIV1)-infected individuals in Casablanca, Morocco. J Infect Dev Ctries 2009;3:380-91.
23. Khan S, Rai MA, Khanani MR, et al. HIV-1 subtype A infection in a community of intravenous drug users in Pakistan. BMC Infect Dis 2006;6:164.
24. Yamaguchi J, Badreddine S, Swanson P, et al. Identification of new CRF43-02G and CRF25-cpx in Saudi Arabia based on full genome sequence analysis of six HIV type 1 isolates. AIDS Res Hum Retroviruses 2008;24:1327-35.
25. Badreddine S, Smith K, van Zyl H, et al. Identification and characterization of HIV type 1 subtypes present in the Kingdom of Saudi Arabia: high level of genetic diversity found. AIDS Res Hum Retroviruses 2007;23:667-74. (Pubitemid 46867463)
26. Alzahrani AJ. Analysis of HIV subtypes and the phylogenetic tree in HIV-positive samples from Saudi Arabia. Saudi Med J 2008;29:1394-6.
27. Hierholzer M, Graham RR, El Khidir I, et al. HIV type 1 strains from East and West Africa are intermixed in Sudan. AIDS Res Hum Retroviruses 2002;18:1163-6. (Pubitemid 35191779)
28. Ben Halima M, Pasquier C, Slim A, et al. First molecular characterization of HIV-1 Tunisian strains. J Acquir Immune Defic Syndr 2001;28:94-6. (Pubitemid 33104533)
29. Yilmaz G, Midilli K, Turkoglu S, et al. Genetic subtypes of human immunodeficiency virus type 1 (HIV-1) in Istanbul, Turkey. Int J Infect Dis 2006;10:286-90. (Pubitemid 43850830)
30. Saad MD, Al-Jaufy A, Grahan RR, et al. HIV type 1 strains common in Europe, Africa, and Asia cocirculate in Yemen. AIDS Res Hum Retroviruses 2005;21:644-8.
31. Thomson MM, Najera R. Molecular epidemiology of HIV-1 variants in the global AIDS pandemic: an update. AIDS Rev 2005;7:210-24. (Pubitemid 43115953)
32. Tagliamonte M, Naderi HR, Tornesello ML, et al. HIV type 1 subtype A epidemic in injecting drug user (IDU) communities in Iran. AIDS Res Hum Retroviruses 2007;23:1569-74.
33. Rai MA, Nerurkar VR, Khoja S, et al. Evidence for a "Founder Effect" among HIV-infected injection drug users (IDUs) in Pakistan. BMC Infect Dis 2010;10:7.
34. WHO, UNICEF, UNAIDS, Yemen. Epidemiological facts sheets on HIV/AIDS and sexually transmitted infections. Geneva, Switzerland: UNAIDS, 2006.
35. Karam W, Aftimos G, Jurjus A, et al. Prevalence of sexually transmitted infections in Lebanese women as revealed by pap smear cytology: a cross sectional study from 2002-2006. Cairo, Egypt, WHO/EMRO 2007.
36. Perrin L, Kaiser L, Yerly S. Travel and the spread of HIV-1 genetic variants. Lancet Infect Dis 2003;3:22-7. (Pubitemid 36041785)
37. Alrajhi AA, Halim MA, Al-Abdely HM. Mode of transmission of HIV-1 in Saudi Arabia. AIDS 2004;18:1478-80. (Pubitemid 38925145)
38. Cuevas MT, Ruibal I, Villahermosa ML, et al. High HIV-1 genetic diversity in Cuba. AIDS 2002;16:1643-53. (Pubitemid 34921110)
39. Thomson MM, Vinogradova A, Delgado E, et al. Molecular epidemiology of HIV-1 in St Petersburg, Russia: predominance of subtype A, former Soviet Union variant, and identification of intrasubtype subclusters. J Acquir Immune Defic Syndr 2009;51:332-9.
40. Iran Ministry of Health. AIDS/HIV surveillance report, fourth quarter. Teheran: Ministry of Health, 2007.
41. Pakistan Ministry of Health. AIDS/HIV surveillance report, third quarter. Islamabad, Pakistan, 2008.
42. Marcelin AG, Grandadam M, Flandre P, et al. Comparative study of heterosexual transmission of HIV-1, HSV-2 and KSHV in Djibouti. 8th Retrovir Oppor Infect (abstract no. 585). Foundation for Retrovirology and Human Health. Chicago, Illinois, USA. 4-8 February 2001.
43. Marcelin AG, Grandadam M, Flandre P, et al. Kaposi's sarcoma herpesvirus and HIV-1 seroprevalences in prostitutes in Djibouti. J Med Virol 2002;68:164-7.
44. Hussein M, Abebe A, Pollakis G, et al. HIV-1 subtype C in commerical sex workers in Addis Ababa, Ethiopia. J Acquir Immune Defic Syndr 2000;23:120-7. (Pubitemid 30316836)
45. Zewde A, Bahiru S, Sanders E, et al. HIV-1 seroprevalence and subtypes in police recruits from Afar regional state, Ethiopia. Ethiop Med J 2002;40(Suppl 1):1-10.
46. Ou CY, Takebe Y, Weniger BG, et al. Independent introduction of two major HIV-1 genotypes into distinct high-risk populations in Thailand. Lancet 1993;341:1171-4. (Pubitemid 23137112)
47. Arroyo MA, Phanuphak N, Krasaesub S, et al. HIV type 1 molecular epidemiology among high-risk clients attending the Thai Red Cross Anonymous Clinic in Bangkok, Thailand. AIDS Res Hum Retroviruses 2010;26:5-12.